These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9155825)

  • 21. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
    FitzGerald JM; Chapman KR; Della Cioppa G; Stubbing D; Fairbarn MS; Till MD; Brambilla R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):427-35. PubMed ID: 10069876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of bronchodilators on diurnal rhythms in airway obstruction.
    Connolly CK
    Br J Dis Chest; 1981 Apr; 75(2):197-203. PubMed ID: 7196770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of fibreoptic bronchoscopy in asthmatic and control subjects and effect on asthma control over two weeks.
    Humbert M; Robinson DS; Assoufi B; Kay AB; Durham SR
    Thorax; 1996 Jul; 51(7):664-9. PubMed ID: 8882070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinically meaningful changes in quantitative measures of asthma severity.
    Karras DJ; Sammon ME; Terregino CA; Lopez BL; Griswold SK; Arnold GK
    Acad Emerg Med; 2000 Apr; 7(4):327-34. PubMed ID: 10805619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Dutch CNSLD Study Group.
    Brand PL; Duiverman EJ; Waalkens HJ; van Essen-Zandvliet EE; Kerrebijn KF
    Thorax; 1999 Feb; 54(2):103-7. PubMed ID: 10325912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Daily psychosocial factors predict levels and diurnal cycles of asthma symptomatology and peak flow.
    Smyth JM; Soefer MH; Hurewitz A; Kliment A; Stone AA
    J Behav Med; 1999 Apr; 22(2):179-93. PubMed ID: 10374142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Observations on the effects of aerosolized albuterol in acute asthma.
    Strauss L; Hejal R; Galan G; Dixon L; McFadden ER
    Am J Respir Crit Care Med; 1997 Feb; 155(2):454-8. PubMed ID: 9032178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The perception of asthma.
    Couriel JM; Demis T; Olinsky A
    Aust Paediatr J; 1986 Feb; 22(1):45-7. PubMed ID: 3718368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between peak expiratory flow rates (PEFR) and FEV1 in the monitoring of asthmatic subjects at an outpatient clinic.
    Gautrin D; D'Aquino LC; Gagnon G; Malo JL; Cartier A
    Chest; 1994 Nov; 106(5):1419-26. PubMed ID: 7956394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Home peak expiratory flow rate monitoring in patients with asthma.
    Li JT
    Mayo Clin Proc; 1995 Jul; 70(7):649-56. PubMed ID: 7791387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of wheezing to the severity of obstruction in asthma.
    Shim CS; Williams MH
    Arch Intern Med; 1983 May; 143(5):890-2. PubMed ID: 6679232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of nebulized magnesium sulfate alone and in combination with salbutamol in acute asthma.
    Sarhan HA; El-Garhy OH; Ali MA; Youssef NA
    Drug Des Devel Ther; 2016; 10():1927-33. PubMed ID: 27354766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should we monitor peak expiratory flow rates or record symptoms with a simple diary in the management of asthma?
    Malo JL; L'Archevêque J; Trudeau C; d'Aquino C; Cartier A
    J Allergy Clin Immunol; 1993 Mar; 91(3):702-9. PubMed ID: 8454792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes of Peak Expiratory Flow Rate in Adult Asthmatic Patient.
    Nasreen S; Nessa A; Islam F; Khanam A; Sultana R; Rahman R; Hossain M
    Mymensingh Med J; 2018 Apr; 27(2):245-250. PubMed ID: 29769485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of the perception of airway obstruction to the severity of asthma.
    Bijl-Hofland ID; Cloosterman SG; Folgering HT; Akkermans RP; van Schayck CP
    Thorax; 1999 Jan; 54(1):15-19. PubMed ID: 10343625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between peak expiratory flow rate and shoulders posture in healthy individuals and moderate to severe asthmatic patients.
    Robles-Ribeiro PG; Ribeiro M; Lianza S
    J Asthma; 2005 Nov; 42(9):783-6. PubMed ID: 16316874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Airway obstruction at time of symptoms prompting use of reliever therapy in children with asthma.
    Brouwer AF; Brand PL; Roorda RJ; Duiverman EJ
    Acta Paediatr; 2010 Jun; 99(6):871-6. PubMed ID: 20151953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma.
    Banov CH; Howland WC; Lumry WR
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):627-32. PubMed ID: 11428734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superiority of ipratropium plus albuterol over albuterol alone in the emergency department management of adult asthma: a randomized clinical trial.
    Lin RY; Pesola GR; Bakalchuk L; Morgan JP; Heyl GT; Freyberg CW; Cataquet D; Westfal RE
    Ann Emerg Med; 1998 Feb; 31(2):208-13. PubMed ID: 9472182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of nebulized ipratropium bromide with salbutamol vs salbutamol alone in acute asthma exacerbation in children.
    Watanasomsiri A; Phipatanakul W
    Ann Allergy Asthma Immunol; 2006 May; 96(5):701-6. PubMed ID: 16729783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.